NCT01933126

Brief Summary

The study aims to examine the effect of intrauterine injection of HCG on pregnany rate in women undergoing IVF treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2013

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 2, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

February 19, 2014

Status Verified

February 1, 2014

Enrollment Period

1.2 years

First QC Date

February 28, 2013

Last Update Submit

February 18, 2014

Conditions

Pregnancy RateImplantation Rate

Outcome Measures

Primary Outcomes (1)

  • Pregnancy rate

    1 year

Study Arms (2)

HCG administration

EXPERIMENTAL

Intrauterine HCG injection

Drug: HCG injection

Placebo

PLACEBO COMPARATOR

G2 Medium

Drug: Placebo

Interventions

HCG injectionDRUG
HCG administration
PlaceboDRUG
Placebo

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women undergoing IVF treatment

You may not qualify if:

  • \> 40 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Harofeh Medical Center

Be’er Ya‘aqov, Zerifin, 70300, Israel

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assaf Harofeh Medical Center

Study Record Dates

First Submitted

February 28, 2013

First Posted

September 2, 2013

Study Start

August 1, 2013

Primary Completion

October 1, 2014

Study Completion

December 1, 2014

Last Updated

February 19, 2014

Record last verified: 2014-02

Locations

IL(1)